Cytogenetic studies of patients suffering from leukemia and treated with "Velbe".
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001854:Bone Marrow Cells; D002869:Chromosome Aberrations / Q000139:chemically induced*; D025063:Chromosome Disorders; D002904:Chromosomes, Human, 21-22 and Y; D002905:Chromosomes, Human, 4-5; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007621:Karyotyping; D007938:Leukemia / Q000188:drug therapy* / Q000532:radiotherapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D007962:Leukocytes / Q000166:cytology; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D011123:Polyploidy; D014314:Trisomy; D014747:Vinblastine / Q000009:adverse effects* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014747:Vinblastine